Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma

Clinical trial NCT00004204 · UNKNOWN

Trial details

NCT number: NCT00004204
Sponsor: Herbert Irving Comprehensive Cancer Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2000-02-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.